Pharmacological Hyperprolactinemia Attenuates Hydrocortisone-Induced Expression of CD11b on Human CD8+ Cells in vivo
Authors:
- Richard ImrichRIRichard Imrich
- Elena TibenskaETElena Tibenska
- Juraj KoskaJKJuraj Koska
- Jozef RovenskyJRJozef Rovensky
- Milan VigasMVMilan Vigas
- 1 April 2004
- journal article
- clinical trial
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 11 (3) , 133-140
Abstract
Objective: To study the short-term influences of pharmacologic hyperprolactinemia on hydrocortisone (HC)-induced effects on selected immune parameters. Methods: A single dose of HC (40 mg per os) was administered to eleven healthy female volunteers 1 h after domperidone (10 mg per os) or placebo administration. Immune cell subsets and expression of adhesion molecules was assessed by flow cytometry at baseline and 4 and 6 h after HC administration. Intracellular staining of interleukin-4 (IL-4) and interferon-gamma (IFN-γ) production in CD4+ lymphocytes after phorbol myristate acetate and ionomycin stimulation was performed at the same time points. Results: HC administration was followed by a significant increase in cortisol levels, numbers of leukocytes and granulocytes and the percentage of CD16+, CD19+, CD11a+, CD11a+CD8+, CD11b+ and CD11b+CD8+ cells. The number of lymphocytes and monocytes and the percentage of CD3+, CD4+, CD4+/CD8+ ratio, CD62L+, CD54+ and CD54+CD16+ cells decreased, while the percentage of CD8+ cells was unaffected. Domperidone administration resulted in a significant increase in prolactin (PRL) concentrations. During hyperprolactinemia, the HC-induced increase in CD11b+CD8+ cells was significantly (p < 0.05) attenuated at 4 h. HC-induced changes in other immune parameters remained unaffected. No significant changes in the intracellular production of IL-4 and IFN-γ in CD4+ lymphocytes were observed after a single dose of HC alone or during hyperprolactinemia. Conclusions: This study shows an attenuated HC-induced increase in CD11b+CD8+ cells in the peripheral blood of healthy females during hyperprolactinemia. Our in vivo observations suggest that short-term interactions occur between PRL and glucocorticoids, affecting selected immune functions. Further studies are needed for confirmation of these results.Keywords
This publication has 15 references indexed in Scilit:
- Effects of D2-dopamine and α-adrenoceptor antagonists in stress induced changes on immune responsiveness of miceJournal of Neuroimmunology, 2002
- Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitorsExperimental Hematology, 2001
- Are adhesion molecules involved in stress-induced changes in lymphocyte distribution?Life Sciences, 2001
- Humoral and Cell-Mediated Immunity in Mice with Genetic Deficiencies of Prolactin, Growth Hormone, Insulin-like Growth Factor-I, and Thyroid HormoneClinical Immunology, 2000
- The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor DeficiencyEndocrine Reviews, 2000
- Growth Hormone (GH) and Prolactin Receptors in Human Peripheral Blood Mononuclear Cells: Relation with Age and GH-Binding ProteinEndocrinology, 1999
- Functional interactions between Stat5 and the glucocorticoid receptorNature, 1996
- Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma.Journal of Experimental Medicine, 1995
- Alterations in interleukin-4 and antibody production following pheromone exposure: Role of glucocorticoidsJournal of Neuroimmunology, 1994
- Expression of prolactin and its receptor in human lymphoid cellsMolecular Endocrinology, 1992